// App-Quantinova.ai

e13001 : Genomic diversity in established melanoma cell lines and human melanoma tumors.

Researchers

Presenter

  • Polina Shindiapina

Principal Investigators

  • Chery A Whipple

  • Jan L Fisher

  • Thomas H Hampton

  • Mary Jo Turk

  • David W. Mullins

  • Craig R Tomlinson

  • Camilo E. Fadul

  • Marc S. Ernstoff

Medical Centers

  • Ohio State University Wexner Medical Center, Columbus, OH

  • The Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Medical Center, Lebanon, NH

  • Section of Hematology/Oncology, Melanoma Program, Dartmouth Hitchcock Medical Center, Lebanon, NH

  • Giesel Medical School at Dartmouth, Dartmouth Hitchcock Medical Center, Lebanon, NH

  • Department of Microbiology and Immunology, Giesel School of Medicine at Dartmouth, Lebanon, NH

  • The Geisel School of Medicine at Dartmouth and Dartmouth Hitchcock Medical Center, Lebanon, NH

  • Division of Neuro-Oncology, University Of Virginia, Charlottesville, VA

  • Roswell Park Cancer Institute, Buffalo, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • AKT Serine

  • B-Raf proto-oncogene, serine/threonine kinase

  • Phosphatase and tensin homolog

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • GTPase Nras

  • HRas Proto-Oncogene, GTPase

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved